Koru Medical Systems Inc (KRMD) said after close Wednesday that it lost $0.02 per share in quarter four 2023. The company reported earnings on an adjusted basis, so it may not be directly comparable to analyst estimates or prior periods.
On the revenue line, the company reported $7.2 million, beating estimates by $246 thousand.
In the same quarter a year ago, the company lost $0.04 per share on revenue of $7.3 million.
The stock is up 3.3% to $2.19 after the report.
The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.
The average recommendation from Wall Street analysts was a Strong Buy which may get revised based on this new data.
Trading in the five days leading up to the report earned Koru Medical Systems Inc a Bearish Sentiment Rank from InvestorsObserver.
Prior to the report, InvestorsObserver gave the stock an overall score of 26. Meanwhile, the average Wall Street analyst rated the stock a Strong Buy.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on home and specialty infusion solutions. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies PIDD and Chronic Inflammatory Demyelinating Polyneuropathy CIDP.
News Home
Koru Medical Systems Inc Up 3.3% To $2.19 After Earnings Beat
Mentioned in this article
